Near-Term Revenue Expected, Says Aequus Pharmaceuticals Inc. (TSXV:AQS) COO

Speaking from the 2015 President’s Club Conference, Anne Stevens, COO and Director of Aequus Pharmaceuticals Inc. (TSXV: AQS), describes how Aequus is a “de-risked” pharmaceutical company with near-term revenue coming from its commercial arm. She also talks about the “blue-sky potential” of her Company’s development pipeline.